Last week we had the announcements of the Nobel Prize winners for 2019. In this post I am going to cover and hopefully explain the work that won the prize for Medicine. It is important to note with a Nobel Prize that it takes years for people’s research to be acknowledged, and the science I shall discuss began back in 1991.
The winners of the Nobel Prize showed an important and unique mechanism in how the body recognises the need for oxygen within our cells. To begin a little information about why oxygen is so important to our survival.
Respiration
The equation for energy and a requirement for us as animals to live:

Oxygen is a necessity for us to live, and our body is able to recognise when we need it and where to distribute it. To start this story oxygen enters our body through the lungs, about 20% of the air we breathe is made up of oxygen. The lungs have a massive blood supply with many blood vessels forming a maze-like lattice, and it is here within the blood that red blood cells specialised carriers for gases lie. As the red blood cells pass through the lungs they will drop off the waste carbon dioxide and collect oxygen ready for transport. The red blood cells have within them an iron containing protein called haemoglobin (this is likely reason you will have heard that iron is good for the blood). Haemoglobin is able to latch onto gases neatly storing them until they reach their destination.
From the lungs the oxygen is transported all over the body for cells to make much needed energy for their day to day functions. Within each and every cell of the body, except the red blood cell, are structures called the mitochondria (you may have heard named the powerhouse of the cell). The oxygen is used in conjunction with glucose from carbohydrates within the process of respiration to create the energy currency that powers everything within the cell.
Specifically this currency is a molecule called adenosine triphosphate (ATP). ATP is inserted into several reactions as effectively the ignition. In the process ATP loses a phosphate creating adenosine diphosphate (ADP). It is the job of respiration to put the P back on creating more ATP. Without ATP nothing would really get done and it is the universal “money” system of the body.
The recent Nobel prize winner for medicine/physiology put work together to show how cells monitor oxygen and respond to a lack of it. Nobel Prizes have been awarded previously in 1938 to Corneille Heymanns who also conducted work on how the body recognises oxygen levels within the blood. Describing the carotid body a collection of oxygen sensitive cells located within the carotid artery. In times of low oxygen signals are sent to the medulla oblongata a crucial region of the brain that controls many processes you need to live from heart rate and blood pressure to breathing and even vomiting. In this case the low oxygen levels trigger an increase in ventilation.
With the basic outline covered we shall move to the work from our Nobel Prize winners; Gregg Semenza, Sir Peter Ratcliffe and William Kaelin Jr.
Red Blood Cell Production
When the body lacks oxygen it enters a state of hypoxia (literally meaning low oxygen). This leads to the increased breathing as mentioned before however this isn’t the only reaction the body has. There is an increase in the production of a hormone called erythropoietin (EPO). Produced by the kidneys this hormone promotes the creation of more red blood cells by the bone marrow. More blood cells mean more carriers of oxygen.
EPO has been used in the past as a performance enhancer for athletes. By stimulating red blood cell production it can be highly beneficial to long distance runners or events that require long term stamina. More of the inhaled oxygen can reach the muscles meaning a slower onset of fatigue and less build up of lactic acid. It an other synthetic versions have been banned since 1990 after their usage between 1987-89.
Semenza’s work was on EPO specificallu the genes that controlled EPO production. As well as how oxygen varied its expression. Together with Ratcliffe they found that there was an oxygen sensing mechanism in pretty much all cells. This was interesting as initial theories would have suggested that this mechanism only within the EPO producing cells of the kidney. Semenza noticed there were genes next to the gene for EPO that also responded to hypoxia.
DNA- deoxyribonucleic acid holds within it the instructions needed to make every cell in your body. Every cell that contains a nucleus has DNA that can be used to make anything the cell needs as long as the right signals are received. When this happens there are enzymes that can read the DNA strand and lead to the production of a protein, for example the EPO gene translates to the production of the EPO hormone.

Through the study of liver cells he identified a complex that bound to the region of the hypoxia related gene. It was dubbed the hypoxia-inducible factor (HIF). Work was then underway to isolate and purify a sample of HIF. In 1995 it was found that the HIF complex was made up of two proteins later named HIF-1α and ARNT (the exact reasoning for these names is not important here).
During periods where oxygen is plentiful the levels of HIF-1α are low and then during hypoxia he amount of HIF-1α increases. This inevitably leading to the reading of the hypoxic related genes. Under normal conditions i.e. not hypoxia any HIF-1α is degraded rapidly. This is conducted by a structure called the proteosome. It will effectively digest the HIF-1α preventing it from causing the activation of these hypoxic genes. However it was not known how HIF-1α degradation by the proteosome was controlled by oxygen levels.
When Research Collides
The answers to these questions were to be found in the work of Kaelin Jr. As a cancer researcher he was investing von Hippel-Lindau’s (VHL) disease. This is caused by an inherited genetic defect (similar to such conditions like cystic fibrosis) leading sufferers to be more prone to various caners including within the nervous system, the retine and the pancreas.
Kaelin’s research showed that the normal VHL gene worked to prevent cancer. Interestingly he also discovered that cells with a dysfunctional VHL gene showed high levels of hypoxia-related genes. When the functional version of the VHL gene was introduced the cells reverted to a non-hypoxic state. The trail of breadcrumbs lead to further discoveries. Not only was it shown that the VHL complex was able to mark other proteins for degradation but Ratcliffe and his lab showed that this VHL complex could interact with HIF-1α. The puzzle was slowly piecing itself together.
How is Oxygen Involved?
We now had a clear picture of the players in this story, but something remained out of focus. How was this system controlled by the levels of oxygen? The answer came with the concurrent release of two papers this showed how levels of oxygen within the cell changed the actual make up of HIF-1α. Under normal conditions where the levels of oxygen are ideal for the health of the cell. The present oxygen actually binds to the HIF-1α altering its protein structure, with this groups now bound the VHL protein recognises it, marking it for degradation. When it’s hypoxic there isn’t enough oxygen for this structural change to occur so the HIF-1α is free to activate the genes needed. This completed the story of how cells are able to sense oxygen.
What Does This Mean?
We now know that HIF-1α is responsible for regulating up to 300 different genes each having a variety of roles in how our body functions. Some of these include our metabolism, response exercise, our development within the womb, and how our bodies adapt to low oxygen environments such as those at high altitudes.
Understanding the ways cells react and adapt to changes in oxygen is crucial for the investigation of several illnesses such as cancers. As most cancers are able to promote a blood supply and blood vessel formation and an increase in red blood cell production. To provide the toxic cells all they need to survive. Obviously there are problems for people with kidney diseases due to an interference in the production of EPO for red blood cells and sufferers of anaemia. Pharmaceutical companies will now be able to use this research to develop new ways of targeting the oxygen sensing mechanisms of cells.
Reading Sources
- Hypoxia-inducible nuclear factors bind to an enhancer element located 3’ to the human erythropoietin gene.
- Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
- The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
- HIFa targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing.
- Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.
- Erythropoietin as a performance-enhancing drug: Its mechanistic basis, detection, and potential adverse effects.




















